What Is a REMS-Certified Spravato Provider? A Patient Guide for Flagstaff, AZ

If you or someone you care about is living with treatment-resistant depression, you may have already encountered the terms “Spravato” and “IV ketamine” during your research. Both treatments represent meaningful advances in psychiatric care, and both are available right here in Flagstaff, AZ, at Healing and Psychiatry. However, the pathways to receiving each treatment differ in important ways – particularly when it comes to federal safety requirements and where you can receive care.

One of the most common questions patients ask involves IV ketamine vs. Spravato accessibility at REMS-certified facilities. Understanding what REMS certification means, why it matters, and how it shapes your treatment options can help you make a more informed decision about the path that may be right for you. This guide breaks down everything Flagstaff-area patients need to know.

What Is Spravato and How Does It Differ from IV Ketamine?

Spravato is the brand name for esketamine, a nasal spray approved by the U.S. Food and Drug Administration (FDA) for treatment-resistant depression in adults and, more recently, for major depressive disorder with acute suicidal ideation or behavior. Esketamine is a derivative of ketamine, meaning the two treatments share a pharmacological foundation but differ in formulation, administration, and regulatory status.

IV ketamine, by contrast, is administered intravenously in a controlled clinical setting. It is used off-label for conditions such as depression, anxiety, PTSD, and chronic pain. While IV ketamine has decades of clinical use supporting its potential benefits, it has not received a specific FDA indication for psychiatric conditions in the way Spravato has. This distinction is significant because it directly influences how each treatment is regulated and delivered.

Key Differences at a Glance

• Administration: Spravato is a self-administered nasal spray used under clinical supervision. IV ketamine is delivered through an intravenous drip managed by medical staff.
• FDA Status: Spravato carries a specific FDA approval for treatment-resistant depression. IV ketamine is used off-label for psychiatric purposes.
• Regulatory Requirements: Spravato must be administered at a REMS-certified facility. IV ketamine does not carry the same federal certification mandate.
• Monitoring Period: Spravato requires a minimum two-hour observation period at the certified facility after each dose.

Understanding REMS Certification and Why It Matters

REMS stands for Risk Evaluation and Mitigation Strategy. It is a safety program required by the FDA for certain medications that carry serious potential risks. The Spravato REMS program was established to ensure that the medication is prescribed, dispensed, and administered only under conditions that adequately manage known risks, including sedation, dissociation, and temporary changes in blood pressure.

For a healthcare facility to offer Spravato, it must be enrolled in the Spravato REMS program. This means the facility has met specific federal requirements, including staff training on proper administration protocols, patient monitoring procedures, and adverse event reporting. Only REMS-certified healthcare settings may dispense and administer Spravato – patients cannot pick it up at a pharmacy or take it at home.

What REMS Certification Requires of a Provider

• The facility must be enrolled and approved through the official Spravato REMS program.
• Healthcare providers prescribing Spravato must complete required training.
• Each patient must be monitored for a minimum of two hours following administration.
• The facility must have protocols in place to manage potential side effects such as sedation or dissociation.
• Proper documentation and reporting must be maintained as part of ongoing compliance.

Healing and Psychiatry in Flagstaff, AZ, is a REMS-certified Spravato provider, meaning our facility meets these stringent federal requirements and our clinical team is specifically trained to deliver this treatment safely.

IV Ketamine vs. Spravato Accessibility at REMS-Certified Facilities

When patients in Flagstaff and across Northern Arizona begin exploring ketamine-based treatments, questions about IV ketamine vs. Spravato accessibility and REMS-certified facilities arise frequently. The regulatory landscape creates meaningful differences in how patients can access each therapy.

Because Spravato requires REMS certification, it is only available at facilities that have completed the enrollment and compliance process. This means that not every psychiatric practice or ketamine clinic can offer it. In a market like Flagstaff – where the number of specialized providers is limited compared to larger metropolitan areas – finding a certified facility is a critical step in the treatment journey.

IV ketamine, on the other hand, can be offered by a wider range of medical providers since it does not fall under the same REMS requirements. However, this broader availability does not necessarily translate to uniform quality of care. Patients seeking IV ketamine should still look for experienced, medically supervised settings with proper monitoring protocols in place.

Accessibility Considerations for Flagstaff Patients

Flagstaff’s position as a regional healthcare hub in Northern Arizona means that residents from surrounding communities often travel to the city for specialized psychiatric services. For patients weighing their options, several accessibility factors are worth considering:

• Provider availability: REMS-certified Spravato facilities are fewer in number than general ketamine providers, making local access especially valuable.
• Insurance coverage: Spravato, as an FDA-approved medication, may be covered by insurance plans. At Healing and Psychiatry, we accept Aetna, Cigna, Horizon, Humana, Medicare, Optum, Tri-Care, and United Healthcare for our services.
• Treatment setting: Both IV ketamine and Spravato require in-office administration with clinical monitoring, so proximity to a qualified provider matters.
• Time commitment: Spravato sessions typically require at least two hours on-site due to the mandatory observation period, while IV ketamine infusion sessions may vary in length depending on the protocol.

What to Expect at a REMS-Certified Spravato Appointment

If you are considering Spravato treatment at Healing and Psychiatry, understanding what a typical appointment looks like can help ease any uncertainty. The REMS framework ensures a consistent, safety-focused experience at every session.

Before Your Appointment

Prior to beginning Spravato treatment, you will meet with a qualified provider at Healing and Psychiatry for a thorough evaluation. This consultation helps determine whether Spravato may be an appropriate option based on your medical history, current symptoms, and previous treatment responses. Our team will also discuss what the treatment involves, potential side effects, and what monitoring will look like.

During Treatment

On the day of your Spravato session, you will self-administer the nasal spray under the direct supervision of trained clinical staff. After administration, you will remain in our facility for the required two-hour observation period. During this time, our team will monitor your vital signs, including blood pressure, and assess for any side effects such as dizziness, nausea, or dissociation. Many patients describe the observation period as a time to rest in a calm, supportive environment.

After Your Session

Patients should not drive or operate heavy machinery for the remainder of the day following a Spravato session. Arranging transportation in advance is essential. Your provider will work with you to establish a treatment schedule – typically twice weekly during the initial phase, with frequency tapering over time based on your response.

Who May Benefit from Spravato or IV Ketamine?

Both Spravato and IV ketamine have been explored as options for individuals who have not responded adequately to conventional treatments. While every patient’s situation is unique, these therapies may be considered for:

• Treatment-resistant depression: Patients who have tried two or more antidepressant medications without sufficient improvement.
• Major depressive disorder with suicidal ideation: Spravato specifically carries an FDA indication for this population.
• Chronic mood disorders: Some patients with persistent anxiety or PTSD symptoms may explore IV ketamine as part of a broader treatment plan.

It is important to note that neither treatment is appropriate for everyone, and outcomes vary from person to person. Many patients experience meaningful improvement, but results are not guaranteed. A thorough clinical evaluation is the best way to determine whether one of these treatments may be suitable for your needs.

Why Choosing a Qualified, Certified Provider in Flagstaff Matters

The growing interest in ketamine-based treatments across Northern Arizona and nationwide in 2026 has led to an increase in the number of providers offering these services. While expanded access is generally positive, it also makes it essential for patients to carefully evaluate where they receive care.

When it comes to IV ketamine vs. Spravato accessibility at REMS-certified facilities, patients in Flagstaff benefit from choosing a provider that offers both treatment modalities under one roof. This allows for a more comprehensive evaluation and the flexibility to transition between therapies if one approach proves more suitable than another. At Healing and Psychiatry, our team is equipped to guide patients through both options with the clinical oversight and personalized attention each treatment requires.

Factors to prioritize when selecting a provider include:

• REMS certification for Spravato, confirming federal compliance and proper staff training.
• Clinical experience with both IV ketamine and Spravato protocols.
• A patient-centered approach that includes thorough evaluation, ongoing monitoring, and individualized treatment planning.
• Accepted insurance plans that may help make treatment more accessible.

Take the Next Step Toward Informed Care

Navigating the landscape of IV ketamine vs. Spravato accessibility and REMS-certified facilities can feel complex, but you do not have to figure it out alone. Healing and Psychiatry is proud to serve patients in Flagstaff, AZ, as a REMS-certified Spravato provider that also offers IV ketamine therapy in a safe, professionally managed clinical environment.

If you are exploring these treatments for treatment-resistant depression or related conditions, we encourage you to reach out to Healing and Psychiatry to schedule a consultation. Our team can help you understand your options, review your treatment history, and develop a plan tailored to your individual needs. Taking the step to learn more is an important part of your path forward.